EXITS

Oncomark, acquired in March 2021 by Cepheid, part of Danaher
Oncomark, acquired in March 2021 by Cepheid, part of Danaher
AventaMed, acquired in February 2023 by Karl Stortz
AventaMed, acquired in February 2023 by Karl Stortz
Embo Medical, acquired in December 2015 by Clearstream, part of CR Bard
Embo Medical, acquired in December 2015 by Clearstream, part of CR Bard